Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis,Cancer Biotherapy and Radiopharmaceuticals

当前位置： X-MOL 学术 › Cancer Biother. Radiopharm. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis
Cancer Biotherapy and Radiopharmaceuticals ( IF 3.4 ) Pub Date : 2021-05-20 , DOI: 10.1089/cbr.2019.3486
Pan Lou ₁ , Tao Ding ₂ , Xu Zhan ₁

Affiliation

Background: Osteosarcoma (OS) is a primary malignant tumor in children and adolescents. Long noncoding RNA HNF1A antisense RNA 1 (HNF1A-AS1) is connected with OS development. However, there are few reports on the role and mechanism of HNF1A-AS1 in OS.

中文翻译：

长链非编码 RNA HNF1A-AS1 通过调节 miR-32-5p/HMGB1 轴调控骨肉瘤进展

背景：骨肉瘤（OS）是儿童和青少年的原发性恶性肿瘤。长链非编码 RNA HNF1A 反义 RNA 1 (HNF1A-AS1) 与操作系统开发有关。然而，关于 HNF1A-AS1 在 OS 中的作用和机制的报道很少。

更新日期：2021-05-22

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>